In HCC, SREBP2 upregulates TAZ expression and increases TAZ interaction with TEAD2 by mediating cholesterol metabolism, thereby promotes HCC through enhanced DNA damage and associated proliferation (Saito et al., 2023). Here, SREBF2 is linked to hepatocellular carcinoma.